EP 1090027 A1 20010411 - NOVEL 17-HALOGENATED 19-NOR STEROIDS, METHOD AND INTERMEDIATES FOR PREPARING SAME, USE AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
Title (en)
NOVEL 17-HALOGENATED 19-NOR STEROIDS, METHOD AND INTERMEDIATES FOR PREPARING SAME, USE AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
Title (de)
NEUE 19-NOR 17-HALO STEROID VERBINDUNGEN, EIN VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG ALS ARTZNEIMITTELN SOWIE PHARMAZEUTISCHE PRÄPARATE DAVON
Title (fr)
NOUVEAUX 19-NOR STEROIDES 17-HALOGENES, PROCEDE ET INTERMEDIAIRES DE PREPARATION, APPLICATION COMME MEDICAMENTS ET COMPOSITIONS PHARMACEUTIQUES LES RENFERMANT
Publication
Application
Priority
- FR 9901491 W 19990622
- FR 9807898 A 19980623
Abstract (en)
[origin: US2003022874A1] A process for the preparation of a compound of the formula wherein the substituents are defined as in the specification.
IPC 1-7
IPC 8 full level
A61K 31/33 (2006.01); A61K 31/565 (2006.01); A61K 31/56 (2006.01); A61K 31/58 (2006.01); A61P 3/06 (2006.01); A61P 5/24 (2006.01); A61P 9/00 (2006.01); A61P 15/12 (2006.01); A61P 19/00 (2006.01); A61P 19/10 (2006.01); C07J 1/00 (2006.01); C07J 41/00 (2006.01); C07J 43/00 (2006.01)
IPC 8 main group level
CPC (source: EP KR US)
A61P 3/06 (2018.01 - EP); A61P 5/24 (2018.01 - EP); A61P 9/00 (2018.01 - EP); A61P 15/12 (2018.01 - EP); A61P 19/00 (2018.01 - EP); A61P 19/10 (2018.01 - EP); C07J 41/00 (2013.01 - KR); C07J 41/0083 (2013.01 - EP US)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
US 2003022874 A1 20030130; US 6566542 B2 20030520; AP 1579 A 20060222; AP 2000002007 A0 20001231; AR 018916 A1 20011212; AT E237628 T1 20030515; AU 4270599 A 20000110; AU 771369 B2 20040318; BR 9912206 A 20010410; CA 2336167 A1 19991229; CN 1313862 A 20010919; CZ 20004834 A3 20010613; CZ 296246 B6 20060215; DE 69906972 D1 20030522; DE 69906972 T2 20040205; DK 1090027 T3 20030804; DZ 2827 A1 20031201; EA 003325 B1 20030424; EA 200100069 A1 20010625; EP 1090027 A1 20010411; EP 1090027 B1 20030416; ES 2196879 T3 20031216; FR 2780060 A1 19991224; FR 2780060 B1 20000804; HK 1039945 A1 20020517; HR P20000893 A2 20011031; HU P0103194 A2 20020128; HU P0103194 A3 20020930; ID 27410 A 20010405; IL 140416 A0 20020210; IL 140416 A 20050725; JP 2002518516 A 20020625; JP 4509380 B2 20100721; KR 20010034919 A 20010425; MA 26656 A1 20041220; MY 118101 A 20040830; NO 20006573 D0 20001221; NO 20006573 L 20010222; NO 318381 B1 20050314; NZ 508535 A 20020828; PL 345073 A1 20011203; PT 1090027 E 20030930; SK 19492000 A3 20010911; TN SN99130 A1 20051110; TR 200003857 T2 20010621; TW 550077 B 20030901; UA 66867 C2 20040615; US 6423700 B1 20020723; WO 9967274 A1 19991229; YU 80700 A 20031031; ZA 200007355 B 20011211
DOCDB simple family (application)
US 17391402 A 20020618; AP 2000002007 A 19990622; AR P990102991 A 19990622; AT 99957166 T 19990622; AU 4270599 A 19990622; BR 9912206 A 19990622; CA 2336167 A 19990622; CN 99809983 A 19990622; CZ 20004834 A 19990622; DE 69906972 T 19990622; DK 99957166 T 19990622; DZ 990127 A 19990622; EA 200100069 A 19990622; EP 99957166 A 19990622; ES 99957166 T 19990622; FR 9807898 A 19980623; FR 9901491 W 19990622; HK 02101559 A 20020228; HR P20000893 A 20001221; HU P0103194 A 19990622; ID 20002721 A 19990622; IL 14041699 A 19990622; JP 2000555925 A 19990622; KR 20007014649 A 20001222; MA 25638 A 19990621; MY PI9902542 A 19990621; NO 20006573 A 20001221; NZ 50853599 A 19990622; PL 34507399 A 19990622; PT 99957166 T 19990622; SK 19492000 A 19990622; TN SN99130 A 19990622; TR 200003857 T 19990622; TW 88109436 A 19990607; UA 01010468 A 19990622; US 72056501 A 20010105; YU 80700 A 19990622; ZA 200007355 A 20001211